XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
shares in Thousands, $ in Thousands
Total
Private Placement
Common stock
Common stock
Private Placement
Additional paid-in capital
Additional paid-in capital
Private Placement
Shareholder note receivable
Treasury Stock
Accumulated other comprehensive income (loss)
Accumulated deficit
Balance at Dec. 31, 2020 $ 129,880   $ 8   $ 770,764   $ (4,000) $ (97) $ 1,204 $ (637,999)
Balance, shares at Dec. 31, 2020     82,104              
Sales agent equity incentives 1,339       1,339          
Stock-based compensation 34,728       34,728          
Sales agent equity incentives, shares     164              
Common stock issued for warrant exercises 3,254       3,254          
Common stock issued for warrant exercises, shares     3,943              
Common stock issued for employee stock purchase plan and stock option exercises 3,584       3,584          
Common stock issued for employee stock purchase plan and stock option exercises, shares     796              
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (12,801)       (12,801)          
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares     1,915              
Issuance of common stock, net of offerings costs   $ 131,828   $ 2   $ 131,826        
Issuance of common stock, net of offerings costs, shares       12,421            
Shareholder note receivable 4,000           $ 4,000      
Repurchase of common stock (25,000)             (25,000)    
Repurchase of common stock, shares     (1,806)              
Purchase of capped calls (39,866)       (39,866)          
Foreign currency translation adjustments (7,240)               (7,240)  
Net Income (Loss) (143,032)                 (143,032)
Balance at Dec. 31, 2021 80,674   $ 10   892,828     (25,097) (6,036) (781,031)
Balance, shares at Dec. 31, 2021     99,537              
Sales agent equity incentives 3,068       3,068          
Stock-based compensation 37,591       37,591          
Sales agent equity incentives, shares     221              
Common stock issued for conversion of Series A preferred stock, shares     29              
Common stock issued for warrant exercises 4,160   $ 1   4,159          
Common stock issued for warrant exercises, shares     3,820              
Common stock issued for employee stock purchase plan and stock option exercises 4,020       4,020          
Common stock issued for employee stock purchase plan and stock option exercises, shares     806              
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (11,220)       (11,220)          
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares     2,204              
Reclassification of liability-classified awards 2,841       2,841          
Common stock issued for asset acquisition 250       250          
Common stock issued for asset acquisition, shares     23              
Foreign currency translation adjustments (4,758)               (4,758)  
Net Income (Loss) (151,293)                 (151,293)
Balance at Dec. 31, 2022 (34,667)   $ 11   933,537     (25,097) (10,794) (932,324)
Balance, shares at Dec. 31, 2022     106,640              
Stock-based compensation 81,244       81,244          
Common stock issued for warrant exercises 670   $ 1   669          
Common stock issued for warrant exercises, shares     5,571              
Common stock issued for employee stock purchase plan and stock option exercises 4,353       4,353          
Common stock issued for employee stock purchase plan and stock option exercises, shares     774              
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability (6,061)       (6,061)          
Common stock issued for vesting of restricted stock units, net of shares withheld for tax liability, shares     6,535              
Issuance of common stock, net of offerings costs 213,183   $ 2   213,181          
Issuance of common stock, net of offerings costs, shares     19,725              
Reclassification of equity-based liability 3,561       3,561          
Foreign currency translation adjustments 2,471               2,471  
Net Income (Loss) (186,638)                 (186,638)
Balance at Dec. 31, 2023 $ 78,116   $ 14   $ 1,230,484     $ (25,097) $ (8,323) $ (1,118,962)
Balance, shares at Dec. 31, 2023     139,245